slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
222,361-222,420 of 319,975
09
Includes a footnote regarding a correction of errors in the financial statements.Nexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
10
Standard financial reporting table showing operating, investing, and financing activities.Nexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
11
The table follows standard financial reporting reconciliation format.Nexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
01
Includes revenue, marketing spend, EBITDA, and comprehensive income comparisons between Q3'22 and Q3'23, alongside franchise-specific performance metrics.Nexters | Results Presentation Deck | 1 slides · GDEV
Conference presentation Investor relations Beat · What Is1 hit
01
The slide uses a high-quality background image of a city to establish the context of urban navigation and GPS technology.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Setup1 hit
02
NextNav | Investor Presentation Deck | 10 slidesNextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Setup1 hit
03
NextNav | Investor Presentation Deck | 10 slidesNextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · What1 hit
04
The slide uses a frequency spectrum diagram to visualize the company's asset position.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Evidence1 hit
05
The slide uses a background image of a city intersection and a series of bottom-aligned photos representing use cases (aviation, ride-sharing, logistics, mobile, emergency services, shipping).NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Evidence1 hit
06
The slide uses a Gantt-style layout to map activities over fiscal years 2023-2026.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · ComplicationLoop · Why Now1 hit
07
The slide uses a split-layout: left side details specific carrier partnerships, right side displays a grid of public safety ecosystem partners.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Core InsightLoop · Why Now1 hit
08
NextNav | Investor Presentation Deck | 10 slidesNextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · ContextLoop · Why Now1 hit
09
The slide uses a hub-and-spoke diagram to organize six key investment pillars around the company logo.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Why Now1 hit
10
NextNav | Investor Presentation Deck | 10 slidesNextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations 1 hit
01
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Attention1 hit
02
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Attention1 hit
03
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Attention1 hit
04
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Attention1 hit
05
Includes three photos of Nikola trucks in operation.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide outlines the recovery and improvement plan for the battery electric truck product line.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations 1 hit
08
Includes renderings of mobile app and vehicle dashboard interfaces.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations 1 hit
09
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations 1 hit
10
The slide presents three distinct financial tables with corresponding bulleted commentary for each section.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes footnotes regarding stock-based compensation.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Why Now1 hit
12
Includes footnotes regarding order status and currency units.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Why Now1 hit
13
Nikola | Results Presentation Deck | 17 slidesNikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
14
The table provides a standard financial reconciliation format.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
15
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
16
The slide provides a standard financial disclosure reconciling GAAP operating cash flow to a non-GAAP 'Adjusted free cash flow' metric.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
17
The slide is a high-quality photograph of the product with the company logo in the bottom right corner.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
01
Nuvalent | Investor Presentation Deck | 52 slidesNuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
02
Nuvalent | Investor Presentation Deck | 52 slidesNuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
03
The slide uses a visual bracket system to connect the core mission statement to three pillars.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
04
The slide combines a pipeline status update with a corporate vision statement.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
05
Includes a grid of headshots for the leadership team and lists for board members and advisors.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
Uses a Venn diagram to illustrate the intersection of solving for resistance and selectivity.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
07
Uses a visual process flow to contrast standard therapy failure with Nuvalent's mechanism.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a visual comparison framework to illustrate the mechanism of action and clinical benefit.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Nuvalent | Investor Presentation Deck | 52 slidesNuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The table highlights the clinical gap in patients with prior kinase inhibitor treatment, specifically those with G2032R mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
11
The table uses a green/white color coding to highlight positive attributes (Yes) versus negative ones (No).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a medical illustration to map specific TRK receptor inhibition side effects to anatomical locations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 values and a bar chart for tumor regression, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses a bar chart to show brain penetrance and a grouped bar chart to show selectivity index, highlighting the drug's potential to avoid off-target CNS effects.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a side-by-side comparison layout to distinguish between the dose escalation (Phase 1) and the registrational intent (Phase 2) study designs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
16
The slide details the transition from the all-treated population to the NSCLC response-evaluable population.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
17
The table highlights a heavily pretreated population, with 77% having received 3 or more prior lines of therapy and 71% having received 2 or more prior ROS1 TKIs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
18
Data as of 13 Sep 22. N=35 patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple efficacy thresholds for ROS1 variants in CNS and peripheral tissues.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
20
Clinical trial data table showing efficacy metrics for NVL-520 in NSCLC patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
22
The chart is a swimmer plot, commonly used in oncology to visualize time-to-event data for individual patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
23
Includes a spider plot (target lesion change) and a bar chart (allele clearance).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
Includes specific patient case study (65-year-old female) and aggregate clinical trial data.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a timeline-style list on the left to show treatment history and a visual 'before-and-after' comparison of medical imaging on the right.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
26
Slide 26 of a pitch deck.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
27
The slide uses a process flow to show the evolution of data from preliminary Phase 1 to updated data shared with the FDA.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
28
Includes detailed clinical trial design, cohort definitions, and study objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
29
The TPP is presented as a list of key product attributes.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit